Skip to main content

Table 1 Baseline patient characteristics

From: Risk factors for complications and mortality of percutaneous endoscopic gastrostomy insertion

 

Total (n = 401)

Pull type (n = 139)

Introducer type (n = 262)

p value

Clinical characteristics

 Age (median, IQR)

68 (57–77)

67 (55–76)

70 (57–77)

0.404

 Gender, male (%)

262 (65.3)

82 (59)

180 (68.7)

0.052

 BMI (median, IQR)

19.5 (17.2–21.7)

20.1 (17.3–23.0)

19.3 (17.1–21.2)

0.017

Indications for PEG, n (%)

 Neurologic disease

240 (59.8)

85 (61.2)

155 (59.2)

0.645

 Malignancy

70 (17.4)

29 (20.8)

41 (15.7)

0.190

 Other

91 (22.7)

25 (18.0)

66 (25.2)

0.086

Comorbidities (%)

212 (52.9)

77 (55.4)

135 (51.5)

0.460

Antibiotic prophylaxis, n (%)

377 (94.0)

124 (89.2)

253 (96.6)

0.003

Concurrent medication, n (%)

 Aspirin

63 (15.7)

26 (18.7)

37 (14.1)

0.230

 Clopidogrel

26 (6.5)

10 (7.2)

16 (6.1)

0.674

 Warfarin

12 (3.0)

4 (2.9)

8 (3.1)

0.922

 Others

23 (5.7)

8 (5.8)

15 (5.7)

0.990

Laboratory values

 WBC/μL

8243.0 ± 3580.2

8083.4 ± 3809.8

8324.6 ± 3461.6

0.528

 Hemoglobin, g/dL

11.2 ± 2.0

11.2 ± 1.9

11.2 ± 2.0

0.987

 Platelets, × 103/μL

266.1 ± 119.1

276.5 ± 137.7

260.8 ± 108.3

0.216

 Albumin, g/dL

3.0 ± 0.7

3.0 ± 0.6

3.0 ± 0.7

0.925

 Prothrombin time, INR

1.06 ± 0.27

1.03 ± 0.27

1.07 ± 0.27

0.826

 CRP, mg/dL

3.0 ± 3.9

3.4 ± 4.4

2.9 ± 3.7

0.283